Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Core Scientific, Inc./tx incurred term loan of $500.0 million with Morgan Stanley Senior Funding, Inc. at term SOFR (subject to a 0% floor), plus an applicable margin of 2.50% per annum maturing the date that is 364 days after the Closing Date.
- Instrument
- term loan
- Principal
- $500.0 million
- Counterparty
- Morgan Stanley Senior Funding, Inc.
- Rate
- term SOFR (subject to a 0% floor), plus an applicable margin of 2.50% per annum
- Maturity
- the date that is 364 days after the Closing Date
- Event
- incurrence
Exact text from the filing
as administrative agent and collateral agent. The Credit Agreement provides for a senior secured loan facility (the “Term Loan Facility”) in an aggregate principal amount of $500.0 million. The Credit Agreement also provides for an accordion feature that allows the Company to request an increase in commitments under the Credit Agreement by up to an additional
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Core Scientific, Inc./tx entered into Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at $500.0 million (effective 2026-03-04).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Morgan Stanley Senior Funding, Inc.
- Value
- $500.0 million
- Effective
- 2026-03-04
Exact text from the filing
On March 4, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into a loan facility Credit Agreement (the “Credit Agreement”), by and among the Company, as borrower, the lenders party thereto from time to time (the “Lenders”) and Morgan Stanley Senior Funding, Inc. (“MSSF”), as administrative agent and collateral agent.
View on SEC.gov